Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock at a price of $30.19 per share on April 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 28, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock.
• The sale was executed at a price of $30.19 per share.
• Following the transaction, Boughton directly owns 159,662 shares of Hims & Hers Health, Inc.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an officer under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of insider trading. The market typically analyzes these sales in aggregate to gauge insider sentiment.

Stakeholder Impact

• The sale of shares by a key officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and overall market sentiment.

Key Dates

Keywords

Hims & Hers Health, Soleil Boughton, Chief Legal Officer, Form 4, Stock Sale, Rule 10b5-1, Insider Trading